Please use this identifier to cite or link to this item:
|Title:||Improving patient monitoring of methotrexate across transitional care settings|
Azzopardi, Lilian M.
|Keywords:||Rheumatism -- Patients -- Care|
Rheumatism -- Chemotherapy -- Malta -- Case studies
Pharmacist and patient
|Publisher:||University of Malta. Department of Pharmacy|
|Citation:||Vella, J., Grech, L., Serracino-Inglott, A., & Azzopardi, L. M. (2017, October). Improving patient monitoring of methotrexate across transitional care settings. Poster session presented at the 46th European Symposium on Clinical Pharmacy, Heidelberg, Germany.|
|Abstract:||A poster presentation about Improving patient monitoring of methotrexate across transitional care settings. Introduction: Rheumatology patients are prescribed disease modifying antirheumatic drugs (DMARD) alone or in combination with biological DMARDs. An interprofessional collaborative team approach, based on an efficient monitoring process is essential, to maximize treatment effectiveness and ensure patient safety particularly as patients transition across different care settings. The pharmacist is a key member of the team positioned to ensure patients’ safety as they transition between primary and secondary care settings. Aim: • To assess compliance towards monitoring needs and laboratory blood tests of rheumatology patients who are treated with methotrexate. • To assess rheumatology patients compliance to prescribed treatment for methotrexate.|
|Appears in Collections:||Scholarly Works - FacM&SPha|
Files in This Item:
|Improving_patient_monitoring_of_methotrexate_across_transitional_care_setting_2017.pdf||1.47 MB||Adobe PDF||View/Open|
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.